1. United Kingdom Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Immunocore Holdings plc

Immunocore Holdings plc

IMCR
Immunocore Holdings plcUS flagNASDAQ Global Select
32.19
USD
-0.31
- -
1.64BMarket Cap

Total Valuation

Immunocore Holdings plc carries a market capitalization of 1.64B, placing it among publicly traded companies globally. Its enterprise value stands at 742.27M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.64B
Enterprise Value742.27M

Share Statistics

Immunocore Holdings plc currently has 50.83M shares outstanding.

Shares Outstanding50.83M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 2.79, and the price-to-book ratio stands at -1.41.

PE RatioN/A
PS Ratio2.79
PB Ratio-1.41
P/TBV Ratio2.92
P/FCF Ratio-60.94
P/OCF Ratio-46.20

Enterprise Valuation

EV / Sales1.80
EV / EBITDAN/A
EV / EBITN/A
EV / FCF72.11

Financial Position

Immunocore Holdings plc maintains a current ratio of 4.18, meaning it holds 4.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 110.67, indicating elevated leverage, while an interest coverage ratio of -2.45 demonstrates limited ability to service its debt obligations.

Current Ratio4.18
Quick Ratio3.86
Debt / Equity110.67
Debt / EBITDA-14.01
Interest Coverage-2.45

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-2.63
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)-108.87
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover0.62

Taxes

Over the trailing twelve months, Immunocore Holdings plc has paid 15.65M in income taxes, reflecting an effective tax rate of 160.49.

Income Tax15.65M
Effective Tax Rate160.49

Stock Price Statistics

Immunocore Holdings plc's stock has declined approximately -0.67294045% over the past 52 weeks. The 50-day moving average sits at 29.20, while the 200-day moving average is 32.52.

Beta (5Y)N/A
52-Week Price Change-0.67294045%
50-Day Moving Average29.20
200-Day Moving Average32.52
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Immunocore Holdings plc generated 412.81M in revenue and converted that into -27.57M in net income, yielding earnings per share of -0.54. EBITDA reached -31.10M, while operating income came in at -34.46M.

Revenue412.81M
Gross Profit408.12M
Operating Income-34.46M
Pretax Income-11.91M
Net Income-27.57M
EBITDA-31.10M
EBIT-34.46M
Earnings Per Share (EPS)-0.54

Balance Sheet

Immunocore Holdings plc holds 844.90M in cash and equivalents against 435.68M in total debt, resulting in a net debt position of -59.01M. Total book value stands at -818.17M, with working capital of 763.69M providing operational flexibility.

Cash & Cash Equivalents844.90M
Total Debt435.68M
Net Debt-59.01M
Equity (Book Value)-818.17M
Book Value Per Share-16.21
Working Capital763.69M

Cash Flow

Immunocore Holdings plc produced -24.92M in operating cash flow over the past twelve months. After subtracting -5.82M in capital expenditures, free cash flow totaled -30.74M - equivalent to -0.61 per share.

Operating Cash Flow-24.92M
Capital Expenditures-5.82M
Free Cash Flow-30.74M
FCF Per Share-0.61

Margins

Immunocore Holdings plc operates with a gross margin of 98.86, reflecting its pricing power and cost economics. The operating margin of -8.35 and net profit margin of -6.68 provide insight into operational efficiency.

Gross Margin98.86
Operating Margin-8.35
Pretax Margin-2.89
Profit Margin-6.68
EBITDA Margin-7.53

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-0.91
FCF Yield-1.64

Scores

Immunocore Holdings plc posts an Altman Z-Score of 1.08, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.08